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Abstract
Study Design: Overview of the methods used for a James Lind Alliance (JLA) Priority Setting Partnership (PSP).
Objectives: The objectives of this article are to (i) provide a brief overview of the JLA—facilitated PSP process; (ii) outline how
research uncertainties were initially processed in the AO Spine RECODE-DCM PSP; and (iii) delineate the methods for interim
prioritization and the priority setting workshop.
Methods: A steering group was created to deﬁne the scope for the PSP, organize its activities, and establish protocols for
decision-making. A survey was created asking what questions on the diagnosis, treatment, and long-term management of DCM
should be answered by future research. Results from the survey were sorted into summary questions. Several databases were
searched to identify literature that already answered these summary questions. The ﬁnal list of summary questions was
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distributed by survey for interim prioritization. Participants were asked to select the top ten most important summary
questions. The questions that were ranked the highest were discussed at an in-person consensus workshop.
Results: The initial survey yielded a total of 3404 potential research questions. Of the in-scope submissions, 988 were related
to diagnosis, 1324 to treatment, and 615 to long-term management of DCM. A total of 76 summary questions were developed
to reﬂect the original submissions. Following a second survey, a list of the top 26 interim priorities was generated and discussed
at the in-person priority setting workshop.
Conclusions: PSPs enable research priorities to be identiﬁed that consider the perspectives and interests of all relevant
stakeholders.
Keywords
James Lind Alliance, priority setting partnership, degenerative cervical myelopathy, surveys and questionnaires, research
uncertainties

Introduction
Priority setting partnerships (PSPs) are designed to develop
research priorities for speciﬁc areas of health care in which
there are considerable research uncertainties.1 A research
uncertainty is deﬁned as any important question about a
speciﬁc area of health care that cannot be convincingly answered by the existing body of evidence.1 Speciﬁcally, a
research uncertainty exists when there are no up-to-date, reliable systematic reviews, or clinical practice guidelines on a
particular topic. PSPs consider the perspectives of clinicians,
patients and caregivers. The James Lind Alliance (JLA)
process consists of gathering research uncertainties from a
wide range of key stakeholders, developing and reﬁning
summary questions that reﬂect these uncertainties and determining the top ten research priorities.
The JLA is a non-proﬁt initiative that facilitates PSPs and
ensures that the proposed research priorities reﬂect the interests of health care professionals, patients, and caregivers.2,3
To date, the JLA has published top ten research priorities for a
wide range of medical and psychiatric conditions, including
psoriasis, pancreatic cancer, depression, and asthma.4-6 According to a report by Staley et al (2020), the impact of a JLA
PSP extends beyond identifying the top ten research priorities.7
The authors suggest a JLA PSP can also encourage patients to
become more involved in future research initiatives, inﬂuence
clinical practice, and facilitate collaboration across funding
organizations and health care departments.
As part of the AO Spine RECODE-DCM (Research Objectives and Common Data Elements for Degenerative Cervical
Myelopathy) project, with the assistance of JLA, a PSP was
initiated for degenerative cervical myelopathy (DCM) in order
to reduce research inefﬁciencies and to set priorities for future
investigation.8 DCM is a progressive, degenerative spine disease and the most common cause of spinal cord dysfunction in
adults worldwide. Based on a study by Smith et al (2020), the
prevalence of DCM is approximately 2.3%.9 Furthermore, as
the global population continues to age, clinicians worldwide
will be required to assess and manage an increasing number of

patients with degenerative spine diseases.10 Given the potential
impact of DCM, it is essential to identify important knowledge
gaps in the literature and to prioritize future research.
Although clinical research in DCM has steadily increased
over the past 2 decades, numerous questions remain unanswered.11 Given the challenges of conducting randomized
controlled trials in this ﬁeld, the level of evidence of published
research is generally rated as insufﬁcient, low, or moderate.
Furthermore, current research largely reﬂects the academic and
clinical interests of the treating physician, which may or may
not be relevant to the patient or caregiver. As a result, research
priorities must be established for DCM that consider the perspectives and interests of clinicians, patients, and caregivers.
The objectives of this article are to (i) provide a brief
overview of the JLA-facilitated PSP process; (ii) outline how
research uncertainties were initially processed in the AO Spine
RECODE-DCM PSP; and (iii) delineate the methods for
interim prioritization and the priority setting workshop.

Part I: An Overview of the James Lind Alliance Process
The steps of a JLA-facilitated PSP are summarized in Figure 1
and include1:
1. Create a steering group with equal representation of
health care professionals and individuals with lived
experience.
2. Gather research uncertainties by distributing a survey
to key stakeholders asking what questions they believe
should be answered by future research.
3. Summarize the responses gathered from the survey and
sort them into overarching themes.
4. Develop clearly formatted summary questions that
reﬂect the original research uncertainties.
5. Check existing evidence to determine whether the
summary questions are true research uncertainties or
whether they have already been answered.
6. Set interim research priorities by redistributing a
survey. Health care professionals and individuals with

Tetreault et al.

Figure 1. An overview of the priority setting partnership process as outlined by the James Lind Alliance.

21S

22S

Global Spine Journal 12(1S)

lived experience are given a list of the summary
questions and are asked to vote on the ones they believe
are the most important.
7. Develop a list of the top ten research priorities that
reﬂect the perspectives of health care professionals and
individuals with lived experience by discussing the
highest ranked 25–30 summary questions at a workshop.
8. Publish and promote the top ten research priorities.

neurologists, 1 primary care physician, 3 physical medicine and
rehabilitation specialists, and twelve individuals with lived
experience. It was the responsibility of this group to deﬁne the
scope of the PSP, organize its activities, and be accountable for
the decisions made in the process. The steering group had full
editorial independence from the sponsors of this initiative.

The JLA also outlines the principles that PSPs should
follow in order to ensure the end product is reliable.1 These
principles include:

An initial survey was distributed to health care professionals
and individuals with lived experience that consisted of the
following four questions:

• The process must be transparent and inclusive.
• The steering group must have equal representation from
health care professionals and individuals with lived
experience. Furthermore, the ﬁnal list of research priorities must reﬂect the interests and perspectives of all
key stakeholder groups.
• Non-clinician researchers must not participate in the
voting process.
• Groups and organizations with signiﬁcant conﬂicts of
interest should not be included in the PSP.
• A detailed audit trail must be completed that outlines the
process from submitted uncertainties to the ﬁnal list of
top ten research priorities.
• Priority setting should not be initiated until the summary
questions have been formally veriﬁed as unanswered.

• Detecting DCM—What question(s) about the diagnosis
of DCM would you like to see answered by research?
• Managing DCM—What question(s) about the treatment
of DCM would you like to see answered by research?
• Living with DCM—What question(s) about the longterm care and follow-up of DCM would you like to see
answered by research?
• What other question(s) about DCM that do not ﬁt into
the above categories would you like to see answered by
research?

Gather Research Uncertainties

Table 1 provides an overview of important terminology that
will be used throughout this section.

These questions were deliberately open-ended to encourage
responses that reﬂect the experiences of a wide range of health
care professionals and individuals with lived experience. There
was also no limit on the number of research uncertainties that
could be submitted by any one individual. The dissemination
strategy and sampling results are detailed in a separate article
within this special edition (Gathering Global Perspectives to
Establish the Research Priorities and Minimum Data Sets for
Degenerative Cervical Myelopathy: Sampling Strategy of the
First Round Consensus Surveys of AO Spine RECODE-DCM)

Create a Steering Group

Summarize the Survey Responses

The steering group of the AO Spine RECODE-DCM PSP
consisted of 6 neurosurgeons, 1 orthopedic spine surgeon, 2

Recruit an Information Specialist. An information specialist was
speciﬁcally recruited to the AO Spine RECODE-DCM PSP to

Part II: A Summary of the Methodology Used in the AO
Spine RECODE-DCM Priority Setting Partnership

Table 1. Important Terminology.
Term

Deﬁnition

Research uncertainty

•Submitted by health care professionals and individuals with lived experience via survey
•Any important question about health care that cannot be answered by the existing body of evidence.
Speciﬁcally, there are either no up-to-date, reliable systematic reviews or clinical practice guidelines that
answer the question, or current evidence indicates that uncertainty exists
•In this paper, the term “research uncertainty” is used interchangeably with survey response, survey submission,
evidence uncertainty and in-scope question
•Developed by the information specialist with input from the steering committee
•An overarching question that summarizes similar submitted research uncertainties
•A summary question that is deemed to be one of the most important and should be answered by future
research
•An individual either diagnosed with or treated for degenerative cervical myelopathy or a caregiver/supporter

Summary question
Research priority
Individuals with lived
experience

Tetreault et al.

23S

Figure 2. An overview of the process from initial survey results to the top ten research priorities.

manage the data. The role of the information specialist was to
review the initial responses of the survey, organize and categorize the submitted uncertainties into themes, generate
summary questions for interim prioritization and check existing literature to verify each summary question is a true
research uncertainty. The following sections will explain the
steps used in the DCM PSP from analyzing the initial survey
results to generating a list of the top ten research priorities.
Organize and Code the Responses from the Initial Survey. A key
principle of a JLA-facilitated PSP is that the PSP must retain an

audit trail from the original survey responses to the ﬁnal list of
research priorities. In order to do this, the information specialist
downloaded an untouched copy of the original survey results.
Survey responses, unique participant identiﬁers and demographic information were then organized into new documents
based on the original survey question (i.e., diagnosis, treatment,
long-term management and follow-up and other).
Blank responses were removed and survey submissions
with multiple parts were divided into individual questions. For
example, the following survey response was separated into
2 parts as it addressed different aspects of diagnosis:

24S

“How can we manage general practitioners and other health care
providers concerning early signs of DCM? How can we improve
the imaging of the earliest signs of myelopathy?”

In some cases, however, submissions with multiple components were not divided if the information specialist believed
the parts were related. For example, the following survey
response was kept as one question:
“Why are people being misdiagnosed? What is it about the DCM
condition that general practitioners are missing? What are the
essential symptoms that should spike a general practitioner to
consider DCM as a possibility? How can DCM be diagnosed at a
much earlier stage?

After initial data processing, there was a total of 3404
research uncertainties that required further sorting. Figure 2
provides an overview of the process from the original 3404
research uncertainties to the top 10 research priorities.

Identify and Remove Out of Scope Questions
The information specialist identiﬁed and removed questions
that were out of scope. These submissions were discussed with
the members of the steering group to ensure that health care
professionals as well as individuals with lived experience
agreed with the decision to remove these questions. Examples
of questions that were considered out of scope included:
1. Questions that did not ﬁt within the deﬁned scope of the
project: “In patients who develop central cord syndrome after mild cervical trauma, in the presence of
existing DCM, is acute decompression or delayed
decompression the best option?”
2. Questions that asked for information or advice. These
submissions typically came from individuals with
DCM or their caregivers and were often already answered: “Any other treatment which can improve life?”
3. Questions that addressed the quality of or access to
health care and social services: “Where can I get help
from a doctor who is familiar with DCM as different
stages develop?”
4. Questions that were too broad or unclear or comments
that did not include a question: “Life after surgery,
what is next? Weakness in both upper or lower limbs?
How to prevent severe complications?”
A total of 414 original submissions were deemed out of
scope and were removed from the data analysis process.
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63 research uncertainties were submitted that did not ﬁt into one
of the three original categories.
All in-scope questions were further sorted into themes based
on content. These themes included deﬁning DCM, investigations, timely diagnosis, disease natural history, nonoperative
and surgical treatment, and long-term management.

Develop Clearly Formatted Summary Questions
Seventy-six clearly formatted questions were developed to reﬂect the original uncertainties. Similar submissions were
grouped together into summary questions in order to signiﬁcantly reduce the volume of data. The JLA offers important
guidance on creating summary questions: (i) they should reﬂect
the language of the original submissions and not introduce new
concepts; (ii) they should not be written like research questions;
and (iii) the language should be accessible to individuals with
DCM and their caregivers but accurate enough to engage health
care providers. Furthermore, it is important that the summary
questions are not too speciﬁc or too broad as this could either
dilute a key theme or make it difﬁcult to interpret.
Supplementary Table 1 provides a list of 76 summary
questions and examples of the original uncertainties. Some of
these questions contain multiple parts in order to adequately
capture the original submissions. The information specialist
and the steering committee agreed that some of the original
uncertainties were similar enough to be categorized under the
same question, but different enough that the question should
be multifaceted.
For example, the following summary question consists of
2 parts: “What are the main signs and symptoms that a patient
with DCM presents with? What are the frequency, sensitivity,
speciﬁcity and positive predictive value of symptoms and signs
(clinical assessments) for DCM?” This multifaceted question
better reﬂects the original uncertainties than either question
does alone: “What are the main symptoms that patients present
with? What is the prevalence of each commonly reported
symptom; which symptom is most sensitive and speciﬁc?”
Present the summary questions to the steering group. Clinicians,
patients and caregivers of the steering group must review the
summary questions and conﬁrm that they reﬂect the original
submissions. Furthermore, members of the steering group
must ensure that the summary questions are clear and unambiguous and that they do not overlap with one another.
The information specialist was responsible for presenting the
summary questions to the steering group. Minor disagreements on
the wording of the questions were resolved through discussion.

Check Existing Evidence
Sort Original Uncertainties Into Categories
A total of 2990 survey submissions were considered in-scope:
988 related to diagnosis, 1324 related to treatment and 615
related to long-term management and follow-up. An additional

Existing evidence must be checked to verify whether the
summary questions reﬂect true research uncertainties. According to the JLA, there are typically only a small number of
questions that have been fully answered by existing research.

Tetreault et al.

A broad search strategy was developed for each question in
order to identify relevant and up-to-date systematic reviews
and clinical practice guidelines. Several databases were
searched, including MEDLINE, MEDLINE in Process, Cochrane Database of systematic reviews, NICE guidelines and
clinicaltrials.gov. If a systematic review or clinical practice
guideline were identiﬁed, the steering group and information
specialist assessed its relevance, quality, and need for updating
or extending. Systematic reviews and clinical practice
guidelines published in the Cochrane database or NICE were
assumed to be reliable and conducted according to methodological standards. If the supporting evidence was identiﬁed
through MEDLINE or another database, its quality was assessed using standardized tools, including GRADE (Grading
of Recommendations, Assessment Development and Evaluation), the Newcastle Ottawa Scale and AMSTAR (A
MeasSurement Tool to Assess Systematic Reviews). Members
of the steering group were also consulted and asked whether
they were aware of any relevant reviews not identiﬁed in the
search or if they knew of researchers working on the topic
area. Supplementary Table 2 summarizes the relevant systematic and narrative reviews and clinical practice guidelines
identiﬁed for each summary question.
Of the 76 summary questions, the information specialist
determined that only two were already answered by existing or
ongoing high-quality research. The steering committee agreed
with this assessment.

Set Interim Research Priorities
The objective of interim prioritization was to condense a long
list of summary questions to a shorter list that could be discussed at the ﬁnal priority setting workshop. To accomplish
this, a second online survey was distributed to a wide group of
stakeholders that asked participants to choose the ten most
important summary questions from a list of 74. This survey
was disseminated through myelopathy.org (an international
charity for DCM) and AO Spine (a non-proﬁt organization
focusing on spinal research, education, and community development) and via email to other health care professionals
and organizations. There were 417 responses in total, of which
310 (74%) were from health care professionals and 107 (26%)
were from individuals with lived experience. Each time a
question was chosen, it was allocated one point. Separate
tallies were maintained for each stakeholder group and were
equally weighted when added together. From this process, a
list of the top 26 summary questions was created to be presented at the ﬁnal workshop. The 26 questions selected for the
workshop are bolded in Supplementary Table 1.

Develop a List of the Top Ten Research Priorities
The ﬁnal stage of a PSP is to establish a list of the top ten
research priorities. This step is done at an in-person workshop,
using a combination of small and whole group discussions.
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This workshop allows participants to exchange knowledge,
clinical expertise and personal experiences in order to develop
priorities that reﬂect the views of all key stakeholders. Furthermore, it facilitates discussions that enable individuals to
broaden their minds when considering the management of
various health care problems. Throughout the priority setting
workshop, the JLA recommends using a Nominal Group
Technique which supports the idea that no individual’s views
or experiences are more valid than another’s. The process,
although rigorous, is also ﬂexible when disagreements arise
and revisions need to be made.
The methods used at the priority setting workshop for
DCM are summarized below:
1. A total of 25 individuals contributed to the priority
setting workshop, including health care professionals
who encounter patients with DCM, individuals with
lived experience and caregivers. Three advisors from the
JLA were also present and were responsible for facilitating the process and ensuring equal involvement by all
stakeholder groups. This workshop was held on November 16th, 2019 in New York City.
2. The 26 questions from the interim prioritization were
randomly sorted and designated a letter from A to Z.
Before the workshop, each participant was required to
review the shortlist of questions and rank them from 1
to 26. Each question was printed on an A4 sized card
with interim priority setting data on the back. This
data included how many survey respondents from
each stakeholder group ranked the question in their
top ten.
3. Participants were allocated to small groups for both a
morning and afternoon session. Each small group had
equal representation of health care professionals and
individuals with lived experience as well as 1 adviser
from the James Lind Alliance.
4. In the morning sessions, each participant was asked to
present the summary questions he or she ranked as the
top 3 and bottom 3. The adviser noted the rankings for
each individual and laid out the cards in rough groups:
questions thought to be the most important, those
thought to be the least important and those either not
mentioned or disagreed upon. Participants then discussed the ordering of the cards and agreed on a
ranking from A to Z. In some cases, the back of the card
was referenced in order to acknowledge the perspectives from the interim prioritization.
5. The 3 advisors entered each groups’ ranking into a
spreadsheet in order to develop a combined rank list.
This list was presented to the whole group.
6. Three new small groups were formed for the afternoon
session in order to discuss and revise the combined
rank list. The revised lists from all 3 groups were
combined into a spreadsheet and an aggregate ranking
was presented to the whole group.

26S

Global Spine Journal 12(1S)

Table 2. The Top Ten Research Priorities for Degenerative Cervical Myelopathy.

1. What strategies can increase awareness and understanding of DCM amongst health care professionals and the public? Can these strategies
help improve timely diagnosis and management of DCM?
2. What is the natural history of DCM? What is the relationship between DCM and asymptomatic spinal cord compression or canal stenosis?
What factors inﬂuence the natural history of the disease?
3. What are the diagnostic criteria of DCM? What is the role of imaging and when should imaging be used in the assessment of DCM?
4. What assessment tools can be used to evaluate functional impairment, disability and quality of life in people with DCM? What instruments,
tools or methods can be used or developed to monitor people with DCM for disease progression or improvement either before or after
surgical treatment?
5. What is the pathophysiology of DCM? What are the mechanisms of neurological injury and the molecular and anatomical consequences?
6. What is the role of rehabilitation following surgery for DCM? Can structured postoperative rehabilitation improve outcome following
surgery for DCM? What are the most effective strategies?
7. Can novel therapies, including stem-cell, gene, pharmacological and neuroprotective therapies, improve the health and wellbeing of people
living with DCM and slow down disease progression?
8. What is the socio-economic impact of DCM? (The ﬁnancial impact of living with DCM to the individual, their supporters and society as a whole)
9. What is the role of dynamic or novel imaging techniques and neurophysiology in the assessment of DCM?
10. Are there clinical and imaging factors that can help a surgeon select who should undergo surgical decompression in the setting of DCM? At
what stage of the disease is surgery the preferred management strategy?

7. The whole group discussed this aggregate ranking and
agreed on the top ten research priorities by the end of
the session.
Table 2 displays the top ten research priorities for DCM.

Publish and Promote the Top Ten Research Priorities
The top ten research priorities are avaliable at aospine.org/recode
and each contextualised in this Global Spine Journal Special
Issue. A detailed knowledge translation strategy was developed
to outline how these priorities will be promoted through publications, conference forums, and online platforms.

Conclusion
Priority setting partnerships enable research priorities to be
developed that consider the perspectives and interests of all
stakeholders, including health care professionals, patients, and
caregivers. The rigorous methodology behind this process
allows numerous initial research uncertainties to be condensed
into a list of the top ten priorities.
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